2021 American Transplant Congress Archives - Page 2 of 139

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

Bamlanivimab for Covid-19 in Kidney Transplant Patients

M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Barriers to Living Kidney Donation: A Closer Look at Declined Donors

M. Anand, S. Barhorst, S. Bumb, B. Abu Jawdeh, T. Kaur, A. Govil
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance

A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea
Basiliximab versus Alemtuzumab: The Association Between Induction Agent and Airway Complications Following Lung Transplantation

M. Furukawa¹, E. G. Chan¹, T. Harano¹, J. Ryan¹, R. Rivosecchi², M. R. Morrell¹, P. G. Sanchez¹
Belatacept and Carfilzomib-based Treatment of Active Antibody-mediated Rejection in a Sensitized Nonhuman Primate Model

J. Kwun¹, R. Schmitz¹, M. Manook¹, Z. Fitch¹, D. Olaso¹, A. Choi¹, J. Yoon¹, Y. Bae¹, J. Lambris², S. Knechtle¹
Belatacept and Rapamycin Maintenance Immunosuppression in a Sensitized Nonhuman Primate Kidney Allotransplantation Model

R. Schmitz¹, Z. W. Fitch¹, M. Manook¹, J. Yoon¹, A. B. Farris², J. Kwun¹, S. J. Knechtle¹
Belatacept Conversion in Elderly Renal Transplant Recipients

M. Durst¹, D. Felix¹, M. Jorgenson¹, J. Descourouez¹, B. C. Astor², D. Mandelbrot²
Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial

O. Efe¹, A. Al Jurdi¹, D. Wojciechowski², K. Safa¹, H. Gilligan¹, A. Chandraker³, J. Azzi³, A. Weins³, L. V. Riella¹
Belatacept Exposure Not Associated With Rejection. Can Doses be Lowered without Compromising Efficacy?

M. McGowan¹, A. Bickenbach¹, B. Miyagawa², A. Christianson¹, T. Mizuno², P. West-Thielke³, J. Leone⁴, E. Woodle¹, D. Kaufman⁵, A. Wiseman⁶, A. Matas⁷, A. Vinks², R. Alloway¹
Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?

J. Pagan¹, S. Anjan², Y. Natori³, A. Fernandez³, R. Zamora-Gonzalez², A. Mattiazzi¹, L. Mendez¹, G. Guerra¹
Belatacept Pharmacokinetic Analysis Comparing Belatacept Early Steroid Withdrawal Trial (BEST) with Benefit and Benefit-ext Trials

A. Bickenbach¹, M. McGowan¹, B. Miyagawa², T. Mizuno², A. Shields³, A. Christianson¹, P. West-Thielke⁴, J. Leone⁵, E. Woodle¹, D. Kaufman⁶, A. Wiseman⁷, A. Matas⁸, A. Vinks²
Belatacept Pharmacokinetics in Patients with and without Infection

A. Bickenbach¹, M. McGowan¹, B. Miyagawa², T. Mizuno², A. Shields³, A. Christianson¹, P. West-Thielke⁴, J. Leone⁵, E. Woodle¹, D. Kaufman⁶, A. Wiseman⁷, A. Vinks², R. Alloway¹
Belatacept Utilization During the Covid-19 Pandemic in the United States

M. MacConmara, A. Shubin, D. Wojciechowski, L. de Gregorio, J. Shah, P. Vagefi, C. S. Hwang
Belatacept-Resistant T Cells are Activated by IFNα-IRF7 Pathway

F. Herr, K. Bargiel, A. Vernochet, A. Durrbach
Beneficial Effects of Argon Inhalation on Reducing Lung Ischemia-reperfusion Injury in Miniature Swine

H. Sahara
Benign Pneumatosis Intestinalis with Pneumoperitoneum in the Immunocompromised Patient: Three Cases

A. Mohamed, K. Delvecchio, T. Kitajima, M. Rizzari, K. Collins, A. Yoshida, S. Nagai, J. Denny, M. Abouljoud
Beta-lactam Allergies Among Solid Organ Transplant Recipients: Prevalence and Association with Transplant Admission Length of Stay

N. N. Pettit¹, V. Nguyen², C. T. Nguyen¹, A. Lew¹, J. Pisano¹, L. M. Potter¹
Better Dialysis Facility Five-Star Rating is Associated with Increased Listing for Kidney Transplantation

J. T. Adler¹, L. Xiang¹, J. S. Weissman¹, J. R. Rodrigue², R. E. Patzer³, S. S. Waikar⁴
Beyond Microarrays: Insights from Ncounter Transcript Analysis of Routine Archival Kidney Allograft Biopsies

I. Rosales, K. Tomaszewski, A. Milagros, T. Kawai, R. Smith, R. Colvin
Bilateral Lung Transplantation for Destroyed Lungs with Asymmetric Thorax

B. Yue, J. Chen
Biliary Complications Following Adult Deceased Donor Liver Transplantation: Risk Factors and Implications at a High-Volume US Center

A. Matar, K. Ross-Driscoll, L. Kenney, H. Wichmann, J. F. Magliocca, W. H. Kitchens
Biomarkers of Kidney Injury and Repair in Expanded-Criteria Deceased Donor Kidney Transplant Recipients: A Prospective Study

A. Al Jurdi¹, O. Efe¹, B. Aoyama², M. Lima², H. Silva², I. Schmidt³, S. Waikar³, V. Sabbisetti⁴, L. V. Riella¹
BK Virus-associated Nephropathy as a Cause of Renal Failure Post-lung Transplantation

A. Arjuna, M. T. Olson, B. Buddhdev, R. Tenorio, A. Omar, S. Tokman
BKV-Associated Urothelial Carcinoma in Patients After Renal and Extrarenal Carcinoma

A. Schwarz¹, J. Schmitz², J. Gottlieb³, C. Bara⁴, H. Haller¹, J. Braesen²
Black Disparity in Access to Kidney Transplant Waitlist Worsens in Illinois After New Kidney Allocation System (kas)

S. Park¹, D. Simpson¹, N. Katariya², J. Friedewald³, B. Ho³, D. P. Ladner¹
Black Patients Do Not Have Worse Short-Term Outcomes After Receiving High KDPI (>85%) Kidneys

K. Atiemo¹, S. Guisti¹, K. Guo², T. Amankonah¹, A. Vijay¹, A. Paramesh¹, M. Killackey¹, H. Jeon¹, L. Zhao², D. Ladner²
Black Patients with Cirrhosis Have Longer Length of Stay and Higher Mortality When Hospitalized

A. Thomas¹, D. Simpson², D. P. Ladner², R. Berkowitz²
Black Transplant Recipients Reside in the Most Socially Vulnerable Communities

A. C. Killian¹, M. C. McLeod¹, B. Shelton¹, R. D. Reed¹, P. MacLennan¹, H. Qu¹, B. J. Orandi¹, D. Sawinski², J. E. Locke¹
Blood Gene Expression and Donor-derived Cell Free DNA for Diagnosing Subclinical Acute Rejection in Stable Kidney Transplant Recipients

S. Park¹, K. Guo², H. Raymond³, E. Poggio⁴, D. Taber⁵, C. Marsh⁶, S. Kurian⁷, S. Kleiboeker⁸, J. Weems⁸, J. Holman⁹, L. Zhao², R. Sinha⁸, S. Brietigam², C. Rebello², M. Abecassis¹⁰, J. Friedewald¹
Blood Pressure Variability Immediately After Liver Transplant Predicts the Likelihood of Long-Term Cardiovascular Events

K. N. Truitt¹, K. Chen², Y. Yano³, D. Gregory⁴, L. B. VanWagner⁵
Blood Type A2/a2b to B Renal Transplantation: A Single Center Retrospective Cohort Study

V. S. Tatapudi, N. Alnazari, R. Chand, N. M. Ali, B. E. Lonze, R. A. Montgomery
Body Mass Index >35 Does Not Impact Kidney Transplant Outcomes or Health Related Quality of Life Despite BMI Class or Recipient Race

D. A. Walczak¹, E. Collins², E. Benedetti¹
Body Surface Adjusted vs Raw GFR in Predicting Long Term Outcomes of Kidney Donors. Who is Disadvantaged?

H. N. Ibrahim¹, S. A. Hebert¹, H. E. Adrogue¹, D. Murad¹, D. T. Nguyen², E. A. Graviss²
Bone Marrow-Derived Mesenchymal Stem Cells Improve Rat Islet Graft Revascularization by Upregulating Isl1

W. Ying, J. Wang, X. Ding
Bortezomib for Antibody-Mediated Rejection of Renal Transplant in Youth

L. Galea, J. Hewlett, J. Savant, S. Lopez, S. Amaral, B. Viteri
Brain Natriuretic Peptide and Pedometer Activity are Most Predictive of Poor Kidney Transplant Waitlist Outcomes

P. Manay¹, P. TenEyck², R. Kalil³, M. Sanders⁴, M. Swee⁴, G. Binns⁵, J. Hornikel⁵, D. Katz¹
Breakthrough Cytomegalovirus DNAemia in High vs Intermediate Risk Heart Transplant Recipients

G. Huang¹, O. E. Beaird¹, M. Davis², M. Carlson¹, S. Chang¹, P. Gaynor¹, A. Fan², M. Deng³, A. Multani¹, A. Nsair³, J. Schaenman¹